Table 1. Patient characteristics . N =... | American Society of Hematology

Table 1.

Patient characteristics

	N = 170	% or range
Age, y
Median	66	20-83
18-60	33	19
>60	137	81
Sex
Male	80	47
Female	90	53
AML subtype
MRC-AML	117	69
t-AML	48	28
Others∗	5	3
Median no. of WBC, G/L	3	0-213
Hyperleukocytosis	16	9
Karyotype
Complex	51	30
Monosomal	32	19
2017 ELN genetic risk stratification
Favorable	8	5
Intermediate	61	36
Adverse	98	58
2022 ELN genetic risk stratification
Favorable	8	5
Intermediate	16	9
Adverse	143	84
Lindsley classifier (N = 107)
de novo/pan-AML	30	28
Secondary-type mutations AML	42	39
TP53-mutated AML	35	33

	N = 170	% or range
Age, y
Median	66	20-83
18-60	33	19
>60	137	81
Sex
Male	80	47
Female	90	53
AML subtype
MRC-AML	117	69
t-AML	48	28
Others∗	5	3
Median no. of WBC, G/L	3	0-213
Hyperleukocytosis	16	9
Karyotype
Complex	51	30
Monosomal	32	19
2017 ELN genetic risk stratification
Favorable	8	5
Intermediate	61	36
Adverse	98	58
2022 ELN genetic risk stratification
Favorable	8	5
Intermediate	16	9
Adverse	143	84
Lindsley classifier (N = 107)
de novo/pan-AML	30	28
Secondary-type mutations AML	42	39
TP53-mutated AML	35	33

WBC, white blood cell.